This synergy between drug and cytokine storm triggered by COVID-19, mainly TNF α, IFN-gamma, LT CD 8+, and Th17 deregulation, can induce a hypersensitivity reaction to the drugs involving toxidermia. Here, IFNG is linked to COVID-19.